Literature DB >> 29320642

ENDOCRINE TREATMENT OF GENDER-DYSPHORIC/GENDER-INCONGRUENT PERSONS: AN ENDOCRINE SOCIETY CLINICAL PRACTICE GUIDELINE.

Wylie C Hembree, Peggy T Cohen-Kettenis, Louis Gooren, Sabine E Hannema, Walter J Meyer, M Hassan Murad, Stephen M Rosenthal, Joshua D Safer, Vin Tangpricha, Guy G T'Sjoen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29320642     DOI： 10.4158/1934-2403-23.12.1437

Source DB:  PubMed          Journal:  Endocr Pract        ISSN： 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  16 in total

1.  A non-surgical approach to 46,XY differences in sex development through hormonal suppression at puberty: a single-center case series study.

Authors:  Katie L Canalichio; Margarett Shnorhavorian; Anne-Marie Amies Oelschlager; Linda Ramsdell; Christina Fisher; Margaret P Adam; Patricia Y Fechner
Journal:  Endocrine       Date:  2020-07-08       Impact factor: 3.633

Review 2.  Psychosocial challenges and hormonal treatment in gender diverse children and adolescents. A narrative review.

Authors:  Laura Baetens; Karlien Dhondt
Journal:  Int J Impot Res       Date:  2020-05-04       Impact factor: 2.896

Review 3.  Interdisciplinary Management of Transgender Individuals at Risk for Breast Cancer: Case Reports and Review of the Literature.

Authors:  Julia Eismann; Yujing J Heng; Kristin Fleischmann-Rose; Adam M Tobias; Jordana Phillips; Gerburg M Wulf; Kari J Kansal
Journal:  Clin Breast Cancer       Date:  2018-11-14       Impact factor: 3.225

4.  Considerations for Transgender People With Diabetes.

Authors:  Joy Moverley; Sarah Loebner; Brent Carmona; David Vuu
Journal:  Clin Diabetes       Date:  2021-10

Review 5.  GnRH agonist-associated pituitary apoplexy: a case series and review of the literature.

Authors:  Francisco J Guarda; Xiaoling Yu; Philip J Saylor; Lisa B Nachtigall; Naila Shiraliyeva; Melanie S Haines; Michael Bradbury
Journal:  Pituitary       Date:  2021-04-09       Impact factor: 4.107

Review 6.  Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus.

Authors:  Melissa E Badowski; Nicholas Britt; Emily C Huesgen; Michelle M Lewis; Misty M Miller; Kathleen Nowak; Elizabeth Sherman; Renata O Smith
Journal:  Pharmacotherapy       Date:  2021-02-27       Impact factor: 4.705

7.  Severe Vasomotor Symptoms Post-Oophorectomy Despite Testosterone Therapy in a Transgender Man: A Unique Case Study.

Authors:  Isabel Casimiro; Ronald N Cohen
Journal:  J Endocr Soc       Date:  2019-02-13

8.  An Observational Study of Hypertension and Thromboembolism Among Transgender Patients Using Gender-Affirming Hormone Therapy.

Authors:  Maria Pyra; Isabel Casimiro; Laura Rusie; Nat Ross; Cori Blum; Kristin Keglovitz Baker; Andie Baker; John Schneider
Journal:  Transgend Health       Date:  2020-03-16

Review 9.  Gender Dysphoria: Bioethical Aspects of Medical Treatment.

Authors:  Marta R Bizic; Milos Jeftovic; Slavica Pusica; Borko Stojanovic; Dragana Duisin; Svetlana Vujovic; Vojin Rakic; Miroslav L Djordjevic
Journal:  Biomed Res Int       Date:  2018-06-13       Impact factor: 3.411

Review 10.  Fertility Options for the Transgender and Gender Nonbinary Patient.

Authors:  Allison C Mayhew; Veronica Gomez-Lobo
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.